D. Merino, N. Lalaoui, and A. Morizot, TRAIL in cancer therapy: present and future challenges, Expert Opinion on Therapeutic Targets, vol.12, issue.10, pp.1299-1314, 2007.
DOI : 10.1136/gut.2004.056929
URL : https://hal.archives-ouvertes.fr/inserm-00527108

A. Almasan and A. Ashkenazi, Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy, Cytokine & Growth Factor Reviews, vol.14, issue.3-4, pp.337-348, 2003.
DOI : 10.1016/S1359-6101(03)00029-7

C. Scaffidi, S. Fulda, and A. Srinivasan, APO-1/Fas) signaling pathways, EMBO J, vol.9517, pp.1675-1687, 1998.
DOI : 10.1093/emboj/17.6.1675
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1170515

S. Fulda, E. Meyer, and C. Friesen, Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis, Oncogene, vol.20, issue.9, pp.1063-1075, 2001.
DOI : 10.1038/sj.onc.1204141

J. Chipuk, T. Moldoveanu, and F. Llambi, The BCL-2 Family Reunion, Molecular Cell, vol.37, issue.3, pp.299-310, 2010.
DOI : 10.1016/j.molcel.2010.01.025

L. Zhang and B. Fang, Mechanisms of resistance to TRAIL-induced apoptosis in cancer, Cancer Gene Therapy, vol.12, issue.3, pp.228-237, 2005.
DOI : 10.1038/sj.cgt.7700792

M. Upreti, E. Galitovskaya, and R. Chu, Identification of the Major Phosphorylation Site in Bcl-xL Induced by Microtubule Inhibitors and Analysis of Its Functional Significance, Journal of Biological Chemistry, vol.283, issue.51, pp.35517-35525, 2008.
DOI : 10.1074/jbc.M805019200

S. Kharbanda, S. Saxena, and K. Yoshida, Translocation of SAPK/JNK to Mitochondria and Interaction with Bcl-xL in Response to DNA Damage, Journal of Biological Chemistry, vol.275, issue.1, pp.322-327, 2000.
DOI : 10.1074/jbc.275.1.322

L. Galligan, D. Longley, and M. Mcewan, Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP, Molecular Cancer Therapeutics, vol.4, issue.12, pp.2026-2036, 2005.
DOI : 10.1158/1535-7163.MCT-05-0262

L. Xu, X. Qu, and Y. Zhang, Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts, FEBS Letters, vol.6, issue.5, pp.943-948, 2009.
DOI : 10.1016/j.febslet.2009.02.014

E. Raymond, S. Faivre, and S. Chaney, Cellular and molecular pharmacology of oxaliplatin, Mol Cancer Ther, vol.1, pp.227-235, 2002.

F. Toscano, Z. Fajoui, and F. Gay, p53-Mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells, Oncogene, vol.32, issue.30, pp.4161-4171, 2008.
DOI : 10.1038/onc.2008.52

O. Micheau, S. Lens, and O. Gaide, NF-??B Signals Induce the Expression of c-FLIP, Molecular and Cellular Biology, vol.21, issue.16, pp.5299-5305, 2001.
DOI : 10.1128/MCB.21.16.5299-5305.2001

M. Fan, M. Goodwin, and T. Vu, Vinblastine-induced Phosphorylation of Bcl-2 and Bcl-XL Is Mediated by JNK and Occurs in Parallel with Inactivation of the Raf-1/MEK/ERK Cascade, Journal of Biological Chemistry, vol.275, issue.39, pp.29980-29985, 2000.
DOI : 10.1074/jbc.M003776200

H. Jin, S. Seo, and S. Woo, A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation, Lung Cancer, vol.61, issue.3, pp.317-327, 2008.
DOI : 10.1016/j.lungcan.2008.01.002

X. Wang, D. Xing, and L. Liu, BimL directly neutralizes Bcl-xL to promote Bax activation during UV-induced apoptosis, FEBS Letters, vol.455, issue.12, pp.1873-1879, 2009.
DOI : 10.1016/j.febslet.2009.04.045

M. Van-delft and D. Huang, How the Bcl-2 family of proteins interact to regulate apoptosis, Cell Research, vol.60, issue.2, pp.203-213, 2006.
DOI : 10.1182/blood-2005-01-0320

K. Wolter, Y. Hsu, and C. Smith, Movement of Bax from the Cytosol to Mitochondria during Apoptosis, The Journal of Cell Biology, vol.15, issue.5, pp.1281-1292, 1997.
DOI : 10.1016/S0092-8674(00)81382-3

S. Shankar and R. Srivastava, Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications, Drug Resistance Updates, vol.7, issue.2, pp.139-156, 2004.
DOI : 10.1016/j.drup.2004.03.002

K. Kondo, S. Yamasaki, and T. Sugie, Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma, International Journal of Cancer, vol.166, issue.1, pp.230-242, 2006.
DOI : 10.1002/ijc.21283

S. Lacour, O. Micheau, and A. Hammann, Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells, Oncogene, vol.22, issue.12, pp.1807-1816, 2003.
DOI : 10.1038/sj.onc.1206127

J. Kim, M. Ajaz, and A. Lokshin, Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis, Clin Cancer Res, vol.9, pp.3134-3141, 2003.

A. Kyritsis, F. Tachmazoglou, and J. Rao, Bortezomib Sensitizes Human Astrocytoma Cells to Tumor Necrosis Factor Related Apoptosis-Inducing Ligand Induced Apoptosis, Clinical Cancer Research, vol.13, issue.21, pp.6540-6541, 2007.
DOI : 10.1158/1078-0432.CCR-07-1447

E. Slee, M. Harte, and R. Kluck, Ordering the Cytochrome c???initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9???dependent Manner, The Journal of Cell Biology, vol.109, issue.2, pp.281-292, 1999.
DOI : 10.1016/S0092-8674(00)80501-2

H. Schulze-bergkamen, R. Ehrenberg, and L. Hickmann, Bcl-xL and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells, World Journal of Gastroenterology, vol.14, issue.24, pp.3829-3840, 2008.
DOI : 10.3748/wjg.14.3829

D. Terrano, M. Upreti, and T. Chambers, Cyclin-Dependent Kinase 1-Mediated Bcl-xL/Bcl-2 Phosphorylation Acts as a Functional Link Coupling Mitotic Arrest and Apoptosis, Molecular and Cellular Biology, vol.30, issue.3, pp.640-656, 2010.
DOI : 10.1128/MCB.00882-09

F. Toscano, B. Parmentier, and Z. Fajoui, p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells, Biochemical Pharmacology, vol.74, issue.3, pp.392-406, 2007.
DOI : 10.1016/j.bcp.2007.05.001

S. Mucha, A. Rizzani, and A. Gerbes, JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand, Gut, vol.58, issue.5, pp.688-698, 2009.
DOI : 10.1136/gut.2008.154625

C. Wang, T. Chen, and N. Zhang, Melittin, a Major Component of Bee Venom, Sensitizes Human Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Activating CaMKII-TAK1-JNK/p38 and Inhibiting I??B?? Kinase-NF??B, Journal of Biological Chemistry, vol.284, issue.6, pp.3804-3813, 2009.
DOI : 10.1074/jbc.M807191200

H. Nakshatri, S. Rice, and P. Bhat-nakshatri, Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase, Oncogene, vol.23, issue.44, pp.7330-7344, 2004.
DOI : 10.1038/sj.onc.1207995

C. Tournier, P. Hess, and D. Yang, Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway, Science, vol.288, issue.5467, pp.870-874, 2000.
DOI : 10.1126/science.288.5467.870

Y. Ito, N. Mishra, and K. Yoshida, Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells, Cell Death and Differentiation, vol.8, issue.8, pp.794-800, 2001.
DOI : 10.1038/sj.cdd.4400886

Y. Kang and S. Lee, The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells, Journal of Cellular Physiology, vol.31, issue.1, pp.23-33, 2008.
DOI : 10.1002/jcp.21470

A. Basu and S. Haldar, Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis, FEBS Letters, vol.8, issue.1-3, pp.41-47, 2003.
DOI : 10.1016/S0014-5793(03)00131-5

S. Desagher, A. Osen-sand, and A. Nichols, Bid-induced Conformational Change of Bax Is Responsible for Mitochondrial Cytochrome c Release during Apoptosis, The Journal of Cell Biology, vol.391, issue.5, pp.891-901, 1999.
DOI : 10.1074/jbc.272.39.24101

R. Eskes, S. Desagher, and B. Antonsson, Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane, Molecular and Cellular Biology, vol.20, issue.3, pp.929-935, 2000.
DOI : 10.1128/MCB.20.3.929-935.2000

S. Baksh, S. Tommasi, and S. Fenton, The Tumor Suppressor RASSF1A and MAP-1 Link Death Receptor Signaling to Bax Conformational Change and Cell Death, Molecular Cell, vol.18, issue.6, pp.637-650, 2005.
DOI : 10.1016/j.molcel.2005.05.010

M. Toscano and C. Umr5201, Reprint requests Address requests for reprints to: Florent, 2010.